Original articles
Safety of regadenoson for vasodilation in cardiac MRI stress tests
Seguridad del empleo de regadenosón como fármaco vasodilatador en resonancia magnética cardíaca de estrés
Read
1562
Timeswas read the article
167
Total PDF
1395
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 25 | 0 | 25 |
| 2025 11 | 0 | 12 | 12 |
| 2025 10 | 91 | 7 | 98 |
| 2025 9 | 106 | 34 | 140 |
| 2025 8 | 80 | 3 | 83 |
| 2025 7 | 86 | 6 | 92 |
| 2025 6 | 89 | 3 | 92 |
| 2025 5 | 89 | 4 | 93 |
| 2025 4 | 95 | 19 | 114 |
| 2025 3 | 67 | 0 | 67 |
| 2025 2 | 62 | 10 | 72 |
| 2025 1 | 55 | 5 | 60 |
| 2024 12 | 37 | 3 | 40 |
| 2024 11 | 47 | 6 | 53 |
| 2024 10 | 38 | 3 | 41 |
| 2024 9 | 42 | 6 | 48 |
| 2024 8 | 33 | 0 | 33 |
| 2024 7 | 27 | 4 | 31 |
| 2024 6 | 27 | 8 | 35 |
| 2024 5 | 12 | 0 | 12 |
| 2024 4 | 18 | 3 | 21 |
| 2024 3 | 23 | 5 | 28 |
| 2024 2 | 49 | 6 | 55 |
| 2024 1 | 28 | 2 | 30 |
| 2023 12 | 26 | 0 | 26 |
| 2023 11 | 25 | 2 | 27 |
| 2023 10 | 47 | 4 | 51 |
| 2023 9 | 18 | 2 | 20 |
| 2023 8 | 12 | 1 | 13 |
| 2023 7 | 8 | 0 | 8 |
| 2023 6 | 7 | 0 | 7 |
| 2023 5 | 6 | 0 | 6 |
| 2023 4 | 8 | 1 | 9 |
| 2023 3 | 3 | 2 | 5 |
| 2023 2 | 4 | 2 | 6 |
| 2023 1 | 2 | 2 | 4 |
| 2021 1 | 1 | 0 | 1 |
| 2020 12 | 1 | 0 | 1 |
| 2020 11 | 1 | 2 | 3 |
Show all
